The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the Jaws

Migliorati, 2005, Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone, Cancer, 104, 83, 10.1002/cncr.21130

Rogers, 1997, Overview of bisphosphonates, Cancer, 80, 1652, 10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z

Berenson, 1997, Bisphosphonates in multiple myeloma, Cancer, 80, 1661, 10.1002/(SICI)1097-0142(19971015)80:8+<1661::AID-CNCR16>3.0.CO;2-Y

Lipton, 1997, Bisphosphonates and breast carcinoma, Cancer, 80, 1668, 10.1002/(SICI)1097-0142(19971015)80:8+<1668::AID-CNCR17>3.0.CO;2-Y

McClung, 2003, Bisphosphonates, Endocrinol Metab Clin North Am, 32, 253, 10.1016/S0889-8529(02)00079-8

Naidu, 2008, The effects of bisphosphonates on osteoblasts in vitro, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 106, 5, 10.1016/j.tripleo.2008.03.036

Santini, 2003, Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients, Clin Cancer Res, 9, 2893

Landesberg, 2008, Inhibition of oral mucosal cell wound healing by bisphosphonates, J Oral Maxillofac Surg, 66, 839, 10.1016/j.joms.2008.01.026

Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004

Etminan, 2008, Use of oral bisphosphonates and the risk of aseptic osteonecrosis: A nested case-control study, J Rheumatol, 35, 1

Koka, 2007, Oral bisphosphonate therapy and osteonecrosis of the jaw: What to tell the concerned patient, Int J Prosthodont, 20, 151

Kyrgidis, 2008, Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients, J Clin Oncol, 26, 1, 10.1200/JCO.2008.16.2768

Wilkinson, 2007, Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A population-based analysis, J Natl Cancer Inst, 99, 1016, 10.1093/jnci/djm025

Durie, 2005, Osteonecrosis of the jaw and bisphosphonates, N Engl J Med, 353, 99, 10.1056/NEJM200507073530120

Wang, 2007, Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy, J Oral Maxillofac Surg, 65, 1328, 10.1016/j.joms.2007.03.006

Bamias, 2005, Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors, J Clin Oncol, 23, 8580, 10.1200/JCO.2005.02.8670

Wessel, 2008, Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: A case-control study, J Oral Maxillofac Surg, 66, 625, 10.1016/j.joms.2007.11.032

Zarynchanski, 2006, Osteonecrosis of the jaw associated with pamidronate therapy, Am J Hematol, 81, 73, 10.1002/ajh.20481

Hewitt, 2007, Bisphosphonate-related osteonecrosis of the jaws: A comprehensive review, J Oral Pathol Med, 36, 319, 10.1111/j.1600-0714.2007.00540.x

Woo, 2006, Systematic review: Bisphosphonates and osteonecrosis of the jaws, Ann Intern Med, 144, 753, 10.7326/0003-4819-144-10-200605160-00009

Yarom, 2007, Osteonecrosis of the jaw induced by orally administered bisphosphonates: Incidence, clinical features, predisposing factors and treatment outcome, Osteoporosis Int, 18, 1363, 10.1007/s00198-007-0384-2

Marx, 2005, Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment, J Oral Maxillofac Surg, 63, 1567, 10.1016/j.joms.2005.07.010

2007

Ruggiero, 2007, Osteonecrosis, 228

Boonyapakorn, 2008, Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies, Oral Oncol, 44, 857, 10.1016/j.oraloncology.2007.11.012

Dodson, 2008, Case 9-2008: A 65-year-old woman with a nonhealing ulcer of the jaw, N Engl J Med, 358, 1283, 10.1056/NEJMcpc0800341

Badros, 2006, Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors, J Clin Oncol, 24, 945, 10.1200/JCO.2005.04.2465

Marx, 2007, Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention and treatment, J Oral Maxillofac Surg, 65, 2397, 10.1016/j.joms.2007.08.003

Freiberger, 2007, Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: A case series, J Oral Maxillofac Surg, 65, 1321, 10.1016/j.joms.2007.03.019

Vescovi, 2006, Bisphosphonate-associated osteonecrosis (BON) of the jaws: A possible treatment?, J Oral Maxillofac Surg, 64, 1460, 10.1016/j.joms.2006.05.042

Migliorati, 2005, Managing the care of patients with bisphosphonate-associated osteonecrosis, J Am Dent Assoc, 136, 1658, 10.14219/jada.archive.2005.0108

Leite, 2006, Bisphosphonate-associated osteonecrosis of the jaws, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, 14, 10.1016/j.tripleo.2005.10.045

Nase, 2006, Osteonecrosis of the jaw and oral bisphosphonate treatment, J Am Dent Assoc, 137, 1115, 10.14219/jada.archive.2006.0350

Adornato, 2007, The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors, J Am Dent Assoc, 138, 971, 10.14219/jada.archive.2007.0294

Levin, 2007, Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment, J Am Dent Assoc, 138, 1218, 10.14219/jada.archive.2007.0346

Allen, 2008, Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment, J Oral Maxillofac Surg, 66, 987, 10.1016/j.joms.2008.01.038

Junquera, 2008, Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant?, J Oral Maxillofac Surg, 66, 1516, 10.1016/j.joms.2008.02.012